FORTE BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7141 USD | +3.46% |
|
-0.31% | -13.09% |
| 03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-05 | Camac Partners Provides Information to Shareholders | CI |
Chart calendar Forte Biosciences, Inc.
c04820b51f2fffd88e2a621dab612504.X5Zz7sD2iBASqSxWOXArLnlmsRg4EmlZAGEEan4nskY.b8Acn4uf5yhnn2YnASRgYiwp6ylTZzEbQQ5yIzAT5B8o20O4t6O8ZWTkHA~878ff20faa758b3c14012e43dee47576
Upcoming events on Forte Biosciences, Inc.
Past events on Forte Biosciences, Inc.
| 18/03/2024 20:05 | Q4 2023 Earnings Release |
| 13/11/2023 21:01 | Q3 2023 Earnings Release |
| 19/09/2023 18:00 | Annual General Meeting - Proxy Fight for Board Representation |
| 14/08/2023 21:01 | Q2 2023 Earnings Release |
| 15/05/2023 21:01 | Q1 2023 Earnings Release |
| 31/03/2023 21:05 | Q4 2022 Earnings Release |
| 14/11/2022 21:01 | Q3 2022 Earnings Release |
| 15/08/2022 21:05 | Interim 2022 Earnings Release |
| 01/06/2022 18:00 | Annual General Meeting |
| 16/05/2022 14:00 | Q1 2022 Earnings Release |
| 07/09/2021 13:00 | Interim 2021 Earnings Call |
| 06/09/2021 | Interim 2021 Earnings Release |
| 27/05/2021 | Annual General Meeting |
| 10/05/2021 21:30 | Q1 2021 Earnings Call |
| 10/05/2021 21:05 | Q1 2021 Earnings Release |
| 24/03/2021 12:30 | FY 2020 Earnings Call |
| 24/03/2021 12:00 | FY 2020 Earnings Release |
| 08/03/2021 18:00 | Chardan Microbiome Medicines Summit |
| 01/03/2021 21:00 | Cowen & Co. Health Care Conference |
| 03/12/2020 16:20 | Evercore ISI HealthCONx Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -46,3 -47,6 2.67% | 0,00 | 0,00 | 0,00 0,00 - | -29,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -46,5 -47,6 2.31% | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
|
Net income Million USD | Released Forecast Spread | -4,07 | -46,5 -47,6 2.37% | -21,7 | -13,9 | 0,00 0,00 - | 0,00 |
|
EPS USD | Released Forecast Spread | -0,41 | -6,32 -7,99 20.93% | -1,55 | -0,80 | 0,00 0,00 - | 0,00 |
| Announcement Date | 25/03/20 | 16/03/21 | 31/03/22 | 31/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | ||
|
EBIT Million USD | Released Forecast Spread | -6,52 | -6,91 | -7,55 | -8,04 | -8,22 | |||||
|
Net income Million USD | Released Forecast Spread | -3,04 | -8,90 | ||||||||
|
EPS USD | Released Forecast Spread | -0,21 | -0,42 | ||||||||
| Announcement Date | 15/08/22 | 14/11/22 | 14/08/23 | 13/11/23 | 18/03/24 | - | - | - | - | - |
More events
Past sector events for Forte Biosciences, Inc.
| 03/05/2024 12:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FBRX Stock
- Calendar Forte Biosciences, Inc.
